Company profile: Bionaut Labs
1.1 - Company Overview
Company description
- Provider of microscale robotic technology for precise delivery of therapies to targeted CNS disease areas; a platform for biologics and small molecules; diagnostic fluid and tissue sampling; long-term in vivo sensing and monitoring; localized electrical stimulation or dampening; and minimally invasive hydrocephalus treatment.
Products and services
- Hydrocephalus treatment: Minimally invasive microsurgical robot constructs therapy addressing obstructions in cerebrospinal fluid circulation for hydrocephalus, focusing on localized intervention within affected pathways
- Microscale robotic technology: Precision-guided microscale robots engineer direct delivery of therapies to targeted disease areas within the central nervous system, achieving highly localized treatment with exact placement
- Therapeutic delivery platform: Targeted-delivery platform creates transport of a wide range of therapeutics, including biologics or small molecules, directly to localized disease areas
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bionaut Labs
Atossa Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for breast cancer, including proprietary (Z)-endoxifen, a SERM for prevention and treatment, and clinical studies: EVANGELINE Phase 2 neoadjuvant trial in ER+/HER2- pre-menopausal women; Karisma Endoxifen Trial to reduce mammographic breast density; and I-Spy 2 evaluating endoxifen to lower recurrence risk in ER+ invasive breast cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atossa Therapeutics company profile →
Focal Medical
HQ: United States
Website
- Description: Provider of targeted therapeutic products using its patent-protected iontophoresis-based delivery system, including IOP Gemcitabine for locally advanced nonresectable pancreatic cancer, IOP Cisplatin for locally recurrent oral cavity cancer, and a program for targeted delivery of genomic medicine to organs without viral vectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Focal Medical company profile →
Qnovia
HQ: United States
Website
- Description: Provider of medtech and pharmaceutical drug-delivery solutions, including RespiRx, an inhalable prescription nicotine replacement therapy for smoking cessation; an inhaled drug delivery platform that optimizes and tracks dosing to improve efficacy and compliance; and a portable, orientation-agnostic vibrating mesh nebulizer with a digital metered dose interface, Bluetooth-enabled app, and a zero-maintenance disposable cartridge.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qnovia company profile →
H&T Presspart
HQ: United Kingdom
Website
- Description: Provider of drug delivery devices and manufacturing services for asthma and COPD, offering metered-dose inhalation devices and components (actuators, dose counters), dry powder inhalers including PowdAir Plus, comprehensive drug delivery device development from design to manufacturing, high-precision injection moulding, automated multi-component assembly, and deep drawing of metal components such as MDI cans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full H&T Presspart company profile →
Retractable Technologies
HQ: United States
Website
- Description: Provider of safety medical products for the healthcare profession, focused on automated needle retraction to reduce needlestick injuries. Offerings include VanishPoint syringes (including U-100 insulin), blood collection sets and tube holders, IV catheters, and EasyPoint retractable needles, with one-handed or in‑vein activation, accurate dose delivery, and reduced disposal space.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Retractable Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bionaut Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bionaut Labs
2.2 - Growth funds investing in similar companies to Bionaut Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bionaut Labs
4.2 - Public trading comparable groups for Bionaut Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →